Valuation : Terumo Corporation

Market Cap 3,297B 21.4B 18.41B 17.37B 15.82B 29.58B 2,046B 29.85B 207B 79.61B 1,038B 80.38B 78.62B P/E 2027 *
16.7x
P/E 2028 * 17.2x
Enterprise Value 3,343B 21.7B 18.66B 17.61B 16.04B 29.99B 2,075B 30.26B 210B 80.72B 1,052B 81.5B 79.72B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.44x
Free-Float
97.07%
Yield 2027 *
1.66%
Yield 2028 * 1.82%
1 week-8.34%
Current month-7.16%
1 month-11.23%
3 months-0.45%
6 months+10.41%
Current year+0.45%
1 week 12.16
Extreme 12.155
13.29
1 month 12.16
Extreme 12.155
14.32
3 years 10.06
Extreme 10.065
19.7
5 years 10.06
Extreme 10.065
21.04
10 years 7.76
Extreme 7.7605
21.04
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-6.87%-17.75%-8.54% 21.78B
-1.78%-4.99%-20.10%+2.61% 182B
-0.29%-1.59%-0.76%+14.58% 118B
-0.73%-4.82%+8.31%+80.61% 61.7B
-2.68%-6.77%+7.91%+39.96% 50.55B
-1.88%-5.97%-6.37%-33.87% 48.98B
+0.75%-5.80%+11.20%-19.01% 31.65B
-4.88%-11.48% - - 29.87B
+2.17%+0.44%+34.88%-12.44% 23.71B
-0.89%-8.92%-13.65%+3.41% 21.78B
Average -1.23%-4.98%+0.41%+7.48% 63.1B
Weighted average by Cap. -1.43%-4.18%-4.73%+11.64%

Financials

2027 *2028 *
Net sales 1,259B 8.17B 7.03B 6.63B 6.04B 11.29B 781B 11.39B 78.97B 30.39B 396B 30.69B 30.02B 1,339B 8.69B 7.48B 7.05B 6.43B 12.01B 831B 12.12B 84B 32.33B 422B 32.64B 31.93B
Net income 195B 1.27B 1.09B 1.03B 935M 1.75B 121B 1.76B 12.23B 4.71B 61.37B 4.75B 4.65B 192B 1.25B 1.07B 1.01B 921M 1.72B 119B 1.74B 12.04B 4.63B 60.4B 4.68B 4.57B
Net Debt 45.99B 299M 257M 242M 221M 413M 28.55B 416M 2.89B 1.11B 14.48B 1.12B 1.1B -26.39B -171M -147M -139M -127M -237M -16.38B -239M -1.66B -637M -8.31B -643M -629M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
-
Date Price Change
10/09/26 €12.26 -0.73%
09/09/26 €12.35 -2.83%
08/09/26 €12.71 -2.68%
07/09/26 €13.06 -1.58%
04/09/26 €13.27 -0.79%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,235.00JPY
Average target price
3,140.77JPY
Spread / Average Target
+40.53%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!